BOSTON--(BUSINESS WIRE)--Halloran Consulting Group, a national consultancy guiding life science companies to optimize development and performance, today announced the expansion of its regulatory and ...
Foxa transcription factors help endow the competence to activate liver genes in development by binding to regulatory sequences in precursor endoderm and opening a local domain of chromatin. Fibroblast ...
When it comes to developing cutting-edge innovations, Astellas aims to be at the forefront. The pharma organisation prides itself on having an open, collaborative, “science first” approach to help ...
The path to rare disease product innovation involves interdependencies between clinical, regulatory, and commercial. Understanding these and the challenges and considerations along the way is integral ...
Drug developers need to understand and anticipate the actions of regulatory agencies such as the FDA and EMA to develop drugs efficiently and effectively. To achieve this, they have traditionally used ...
The pharmaceutical sector is experiencing growth through market expansion and global collaboration. To encourage this growth, compliance with regulations in Chemistry, Manufacturing, and Controls (CMC ...
Franklin Biolabs, a fully integrated preclinical contract research organization (CRO) at the forefront of genetic medicine and biologics innovation, and RareMoon Consulting, a regulatory services ...
The National Academies Forum on Drug Discovery, Development, and Translation convened this public workshop to examine the state of the science of drug regulation and consider approaches for enhancing ...
The concept of regulatory science is not a new one. The FDA Science Board’s 2007 Science and Mission at Risk report (FDA Science Board, 2007) describes regulatory science as a science-based ...
That perception is outdated, however, as regulatory strategy now represents a source of competitive advantage rather than mere compliance. Regulatory expertise can de‑risk programs, accelerate ...
Join us for a deep dive into the complexities of regulatory submissions, where we’ll explore key requirements and best practices for compiling, writing, and reviewing dossiers. Learn how Lonza’s Small ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results